690 results match your criteria: ""Puerta de Hierro-Majadahonda" University Hospital[Affiliation]"

Background And Aims: Long-term safety and efficacy of mavacamten in patients with obstructive hypertrophic cardiomyopathy (HCM) are unknown. MAVA-LTE (NCT03723655) is an ongoing, 5-year, open-label extension study designed to evaluate the long-term effects of mavacamten.

Methods: Participants from EXPLORER-HCM (NCT03470545) could enrol in MAVA-LTE upon study completion.

View Article and Find Full Text PDF
Article Synopsis
  • An online survey of European thyroid specialists revealed that 28% believe thyroid hormone (TH) treatment may be appropriate for euthyroid patients with growing simple goiters, despite guidelines against this practice.
  • There were significant regional differences in support for TH treatment, with only 7% in The Netherlands compared to 78% in the Czech Republic.
  • Factors influencing the likelihood of recommending TH included the specialist's age and the historical iodine insufficiency of their region, while gender, country, and economic factors showed weak associations.
View Article and Find Full Text PDF

Background: Thoracic discectomy procedures require early and adequate pain control to alleviate patient discomfort after surgery. The intraoperative placement of a nerve block after intercostal nerve violation can offer early pain management after thoracic discectomy.

Methods: The anatomy and technique of placing an intercostal nerve block after retropleural thoracic discectomy are described.

View Article and Find Full Text PDF

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

N Engl J Med

January 2025

From the National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital (M.F., J.D.G.), and Richmond Pharmacology (J.T.), London, and the Institute of Cardiovascular and Medical Sciences, British Heart Foundation Glasgow Cardiovascular Research Centre, Glasgow (M.C.P.) - all in the United Kingdom; Boston University School of Medicine (J.L.B.) and the Cardiovascular Division, Brigham and Women's Hospital (S.D.S.) - both in Boston; the Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA (R.M.W.); the Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN (M.G.); the Division of Cardiology, Penn Presbyterian Medical Center, University of Pennsylvania Health System, Philadelphia (B.D.); the Cardiology Department and French National Reference Centre for Cardiac Amyloidosis, GRC Amyloid Research Institute and Clinical Investigation Centre 1430 at Hôpitaux Universitaires Henri-Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP), and Institut Mondor de Recherche Biomédicale, INSERM, Université Paris Est Creteil, Creteil (T.D.), and the Department of Cardiology, French National Reference Center for Cardiac Amyloidosis, Bichat University Hospital, AP-HP, Paris (V.A.) - all in France; the Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Health Research Institute of the Puerta de Hierro Majadahonda-Segovia, Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBER-CV), and Centro Nacional de Investigaciones Cardiovasculares (P.G.-P.), and CIBER-CV (J.G.-C.), Madrid, and the Department of Cardiology, Hospital Universitari de Bellvitge, Instituto de Investigación Biomédica de Bellvitge, and Universitat de Barcelona, Barcelona (J.G.-C.) - all in Spain; MedStar Heart and Vascular Institute, MedStar Health, and Georgetown University School of Medicine - both in Washington, DC (F.H.S.); the Division of Cardiovascular Medicine, Department of Medicine, Kurume University School of Medicine, Kurume (N.T.), and the Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto (K.T.) - both in Japan; the Department of Clinical Research and Epidemiology, Comprehensive Heart Failure Center, University Hospital Würzburg, and the Department of Medicine I, University Hospital Würzburg, Würzburg (C.M.), and the Division of Cardiovascular Imaging, University Hospital Münster, Münster (A.Y.) - both in Germany; the Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary (Z.P.); the Department of Cardiology, University Health Network of Toronto, Toronto (D.D.); University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (P.V.M.); the Victor Chang Cardiac Research Institute, the Cardiology Department, St. Vincent's Hospital, and the School of Clinical Medicine, University of New South Wales - all in Sydney (A.J.); the Department of Cardiology, Hôpital Universitaire de Bruxelles-Hôpital Erasme, Université Libre de Bruxelles, Brussels (A.B.); the Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (D.K.); the Cardiology Department, Hospital Senhora da Oliveira-Guimarães, Guimarães, and the School of Medicine, University of Minho, Braga - both in Portugal (O.A.); the Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark (S.H.P.); the Division of Translational Cardiology and Clinical Registries, Institute of Heart Diseases, Wrocław Medical University, Wrocław, Poland (E.A.J.); Alnylam Pharmaceuticals, Cambridge, MA (A.S., P.P.G., K.L.B., E.Y., N.S., L.Y., J.C., S.A.E., J.V.); and Columbia University Irving Medical Center, New York (M.S.M.).

Article Synopsis
  • Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a serious, progressive disease, and vutrisiran is a new treatment that works by reducing the production of transthyretin in the liver.
  • In a double-blind trial involving 655 patients, those receiving vutrisiran had a lower risk of death and cardiovascular events compared to those on placebo, demonstrating significant efficacy.
  • Vutrisiran also improved patient outcomes, showing less decline in walking distance and quality of life measurements over the study period compared to placebo.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the prevalence and characteristics of transthyretin amyloid cardiomyopathy (ATTR-CM) in older patients with hypertrophic cardiomyopathy of unknown causes, amidst rising recognition of this condition due to better diagnostic techniques.
  • Conducted across 20 hospitals in 11 countries, the TTRACK study included patients aged 50 and older with specific echocardiography findings, who underwent imaging tests to evaluate cardiac involvement.
  • Results showed that 18.8% of patients had transthyretin amyloid cardiomyopathy, with notable findings including a correlation to symptoms of heart failure and a significant association with carpal tunnel syndrome among patients.
View Article and Find Full Text PDF

We conducted a multicenter and retrospective study to describe the use of botulinum toxin type A (BoNT-A) to treat post-stroke spasticity (PSS). Data were extracted from free-text in electronic health records (EHRs) in five Spanish hospitals. We included adults diagnosed with PSS between January 2015 and December 2019, stratified into BoNT-A-treated and untreated groups.

View Article and Find Full Text PDF

Lung cancer surgery with curative intent has significantly developed over recent years, mainly focusing on minimally invasive approaches that do not compromise medical efficiency and ensure a decreased burden on the patient. It is directly linked with an efficient multidisciplinary team that will perform appropriate pre-operative assessment. Caution is required in complex patients with several comorbidities to ensure a meaningful and informed thoracic surgery referral leading to optimal patient outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists wanted to see if a new method called hypothermic oxygenated machine perfusion (HOPE) is better for keeping donor hearts alive before they are transplanted, compared to the traditional cold storage method.
  • They did a big study with 229 patients across 15 transplant centers in Europe to compare these two methods.
  • The main goal was to find out if using HOPE reduces serious problems after heart transplant surgery, like heart failure or rejection, within the first 30 days.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on assessing the quality of care for patients with non-small cell lung cancer (NSCLC) using hospital data to enhance continuous quality improvement in cancer care.
  • Conducted at a university hospital in Spain, the research utilized a retrospective cohort approach from 2016 to 2020, analyzing 34 quality indicators derived from guidelines and literature.
  • Results indicated strong adherence to clinical guidelines and positive survival outcomes, showcasing a methodology that leverages hospital data to track and improve healthcare quality over time.
View Article and Find Full Text PDF

Background: Despite advances in lung cancer treatment and the subsequent improvement in oncological outcomes, the optimal frequency of radiological follow-up remains unclear. Current recommendations lack consensus and do not consider individual patient characteristics and tumor factors. This study aimed to examine the impact of radiological follow-up frequency on oncological outcomes following lung cancer resection.

View Article and Find Full Text PDF

Objectives: Lung Cancer (LC) is a multifactorial disease for which the role of genetic susceptibility has become increasingly relevant. Our aim was to use artificial intelligence (AI) to analyze differences between patients with LC based on family history of cancer (FHC).

Materials And Methods: From August 2016 to June 2020 clinical information was obtained from Thoracic Tumors Registry (TTR), a nationwide database sponsored by the Spanish Lung Cancer Group.

View Article and Find Full Text PDF

The objective of this paper was to determine how different types of posterior staphyloma (PS) may affect the appearance and degree of myopic maculopathy. A cross-sectional study was conducted, in which 467 eyes from 246 highly myopic patients [axial length (AL) ≥ 26 mm] were studied. A complete ophthalmic exploration was carried out on all patients, including imaging tests.

View Article and Find Full Text PDF

Plocabulin (Plo) induces depolymerization of tubulin fibers with disorganization and fragmentation of the microtubule network leading to mitosis. Plo combined with gemcitabine (Gem) showed synergistic anti-tumor activity in preclinical studies. This phase I trial evaluated the safety, pharmacokinetics (PK) and efficacy of Plo 10-min infusion plus Gem on Day 1 and 8 every 3-week in patients with advanced solid tumors.

View Article and Find Full Text PDF
Article Synopsis
  • Statins provide multiple benefits for patients with metabolic-associated steatotic liver disease (MASLD), particularly in reducing long-term risks of all-cause mortality and liver-related clinical events (LREs).
  • A study followed 7988 patients for nearly 4.6 years, revealing that statin users had significantly lower risks of mortality (HR=0.233) and LREs (HR=0.380), as well as slower liver stiffness progression rates.
  • While statin usage is linked to a decrease in the progression of liver stiffness, it did not significantly correlate with liver stiffness regression, suggesting a complex relationship in liver health management.
View Article and Find Full Text PDF

Patients with Post-viral long hauler encompass lasting symptoms and comorbid complexities, often exacerbated in individuals with excessive body weight. The aim was to study gut microbiota in 130 patients with post-viral long hauler stratified by body mass index (BMI) and the relationship between inflammation and microbiota. Significant higher values were found for anthropometric variables and markers of glucose and dyslipidemia in individuals with higher BMI, as well as elevated levels of C-reactive protein, fibrinogen, IL-6, uric acid, and D-dimer.

View Article and Find Full Text PDF

IgA Anti-β2-Glycoprotein I Antibodies as Markers of Thrombosis and Severity in COVID-19 Patients.

Viruses

July 2024

Systemic Autoimmune Diseases Unit, Department of Internal Medicine, IDIPHIM (Puerta de Hierro University Hospital Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.

Patients with COVID-19 may develop a hypercoagulable state due to tissue and endothelial injury, produced by an unbalanced immune response. Therefore, an increased number of thromboembolic events has been reported in these patients. The aim of this study is to investigate the presence of antiphospholipid antibodies (aPL) in COVID-19 patients, their role in the development of thrombosis and their relationship with the severity of the disease.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how specific immune cell types in blood samples from patients with metastatic castration-resistant prostate cancer (mCRPC) can affect survival rates.
  • Researchers analyzed pre-treatment blood samples from 152 patients and found that lower CD8 T-cell counts and higher monocyte levels were linked to shorter survival.
  • Their results suggest that these immune cell types could act as important biomarkers for mCRPC management, supporting the need for further research in clinical trials.
View Article and Find Full Text PDF

Optical Coherence Tomography (OCT) imaging is a valuable tool for complex coronary interventions. While complications are rare, the occurrence of ventricular arrhythmias during its use is one of the most feared. Unfortunately, the mechanism by which these arrhythmias arise remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to evaluate the effectiveness of combining hypertonic saline solution (HSS) with furosemide in treating patients with worsening heart failure, focusing on potential improvements in diuretic response in an outpatient setting.
  • The results showed no significant difference in short-term diuresis or natriuresis between the two treatment groups; however, the Furosemide-HSS group had slightly decreased weight after 7 days.
  • Overall, the combination therapy did not lead to better outcomes in terms of congestion or kidney function compared to furosemide alone, suggesting it may not be beneficial in this context.
View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed the management and mortality outcomes of nontuberculous mycobacterial (NTM) infections in solid organ transplant (SOT) recipients, focusing on data from 2008 to 2018.
  • Out of 85 patients with NTM infections and 169 matched controls, one-year mortality was significantly higher in the infected group (20%) compared to controls (3%), particularly among those who had lung transplants.
  • Factors like time to treatment and changes in immunosuppression levels did not show a direct correlation with mortality rates among the patients.
View Article and Find Full Text PDF

While allograft rejection (AR) continues to threaten the success of cardiothoracic transplantation, lack of accurate and repeatable surveillance tools to diagnose AR is a major unmet need in the clinical management of cardiothoracic transplant recipients. Endomyocardial biopsy (EMB) and transbronchial biopsy (TBBx) have been the cornerstone of rejection monitoring since the field's incipience, but both suffer from significant limitations, including poor concordance of biopsy interpretation among pathologists. In recent years, novel molecular tools for AR monitoring have emerged and their performance characteristics have been evaluated in multiple studies.

View Article and Find Full Text PDF

BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC.

Lung Cancer

August 2024

Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain. Electronic address:

Article Synopsis
  • Immunotherapy treatments show high effectiveness in advanced non-small-cell lung cancer (NSCLC), but the impact of BRAF mutations in these cases is unclear.
  • In a study of 116 stage IIIA/B and 84 stage IV patients, BRAF mutations were found in a small percentage, with all patients who had these mutations remaining alive and disease-free at the study's cutoff.
  • BRAF-mutated patients had a 100% pathological complete response rate to neoadjuvant chemoimmunotherapy compared to a 44.3% rate in BRAF wild-type patients, suggesting that BRAF mutations could indicate better outcomes for those undergoing immunotherapy.
View Article and Find Full Text PDF

Digital Transformation in Thoracic Surgery: a survey among the European Society of Thoracic Surgeons.

Interdiscip Cardiovasc Thorac Surg

July 2024

Department of Thoracic Surgery, Harefield Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.

Objectives: Digital transformation has drastically changed the surgical sector, but few is known about its impact on thoracic surgical practice. The aim of this paper is to report the European Society of Thoracic Surgeons (ESTS) survey results, assessing the impact of and the need for Digital Transformation in Thoracic Surgery.

Methods: A 23-item survey was designed by the ESTS Digital Transformation Working Group to assess the impact of and the need for Digital Transformation in Thoracic Surgery.

View Article and Find Full Text PDF
Article Synopsis
  • Medical laboratories must document various activities to maintain service quality, leading to the generation of multiple documents, forms, and reports.
  • Each document's retention time must be specified, adhering to national laws or professional guidelines, with a defined retention schedule created when guidelines are lacking.
  • The EFLM Working Group offers recommendations for retention periods based on a risk-based approach (FMEA), aligning with ISO 15189:2022 for general quality management.
View Article and Find Full Text PDF